Related references
Note: Only part of the references are listed.An appraisal of emerging second line therapies for metastatic colorectal cancer
Cristina Smolenschi et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5-fluorouracil and leucovorin combination as first- or second-line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial
Pasquale F. Innominato et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Management of disappearing colorectal liver metastases: an international survey
Laleh G. Melstrom et al.
HPB (2021)
Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM
R. Vera et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial
John A Bridgewater et al.
LANCET ONCOLOGY (2020)
Hepatic metastases resection after cetuximab: are we missing something?
Ayhan Ulusakarya et al.
LANCET ONCOLOGY (2020)
Chemotherapeutic Effectiveness of Combining Cetuximab for Metastatic Colorectal Cancer Treatment: A System Review and Meta-Analysis
Rong Li et al.
FRONTIERS IN ONCOLOGY (2020)
Evaluation of the Use of Cancer Registry Data for Comparative Effectiveness Research
Abhishek Kumar et al.
JAMA NETWORK OPEN (2020)
The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis
Yoshikuni Kawaguchi et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Genetic Alterations of Metastatic Colorectal Cancer
Ugo Testa et al.
BIOMEDICINES (2020)
Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review
Karen Bolhuis et al.
EUROPEAN JOURNAL OF CANCER (2020)
Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis
Xianzhe Yu et al.
ONCOTARGETS AND THERAPY (2020)
Immune scores in colorectal cancer: Where are we?
David Malka et al.
EUROPEAN JOURNAL OF CANCER (2020)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Prognostic and predictive markers in liver limited stage IV colorectal cancer
Adeeb H. Rehman et al.
EJSO (2019)
Adjuvant Chemotherapy With or Without Biologics Including Antiangiogenics and Monoclonal Antibodies Targeting EGFR and EpCAM in Colorectal Cancer: A Systematic Review and Meta-analysis
Pablo E. Serrano et al.
JOURNAL OF SURGICAL RESEARCH (2019)
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis
Antonio Galvano et al.
CANCERS (2019)
Multidisciplinary approach of liver metastases from colorectal cancer
Rene Adam et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2019)
How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective
Katsunori Imai et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2019)
Biomarkers in colorectal liver metastases
S. Yamashita et al.
BRITISH JOURNAL OF SURGERY (2018)
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
A. Grothey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Capecitabine Versus Continuous Infusion Fluorouracil for the Treatment of Advanced or Metastatic Colorectal Cancer: a Meta-analysis
Zehua Wu et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Resection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients
Rene Adam et al.
EUROPEAN JOURNAL OF CANCER (2017)
FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer A Systematic Review and Pooled Analysis
Gianluca Tomasello et al.
JAMA ONCOLOGY (2017)
Oral versus intravenous fluoropyrimidines for colorectal cancer
Fiona Chionh et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection
G. Poston et al.
EJSO (2017)
Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection
G. Duwe et al.
EJSO (2017)
RAS mutation prevalence among patients with metastatic colorectal cancer: a meta-analysis of real-world data
George Kafatos et al.
BIOMARKERS IN MEDICINE (2017)
Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV
F. A. Levi et al.
ANNALS OF ONCOLOGY (2016)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases
K. W. Brudvik et al.
BRITISH JOURNAL OF SURGERY (2015)
Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus
Rene Adam et al.
CANCER TREATMENT REVIEWS (2015)
Role of First-Line Anti-Epidermal Growth Factor Receptor Therapy Compared With Anti-Vascular Endothelial Growth Factor Therapy in Advanced Colorectal Cancer: A Meta-Analysis of Randomized Clinical Trials
Muhammad A. Khattak et al.
CLINICAL COLORECTAL CANCER (2015)
Role of Neoadjuvant Chemotherapy in Resectable Synchronous Colorectal Liver Metastasis; an International Multi-Center Data Analysis Using Livermetsurvey
Glenn K. Bonney et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
Management and Outcome of Colorectal Cancer Liver Metastases in Elderly Patients A Population-Based Study
Christopher M. Booth et al.
JAMA ONCOLOGY (2015)
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2014)
KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
A. I. Phipps et al.
BRITISH JOURNAL OF CANCER (2013)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger et al.
LANCET ONCOLOGY (2013)
5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trials
Fausto Petrelli et al.
MEDICAL ONCOLOGY (2012)
The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus
Rene Adam et al.
ONCOLOGIST (2012)
Clinical outcome of panitumumab for metastatic colorectal cancer with wild-type KRAS status: a meta-analysis of randomized clinical trials
Ezzeldin M. Ibrahim et al.
MEDICAL ONCOLOGY (2011)
Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise?
Dhanwant Gomez et al.
HPB (2010)
Chemotherapy-Associated Hepatotoxicity: Do We Need to Be Concerned?
Michael A. Choti
ANNALS OF SURGICAL ONCOLOGY (2009)
Urgent need for a new staging system in advanced colorectal cancer
Graeme J. Poston et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prognostic Variables for Resection of Colorectal Cancer Hepatic Metastases: An Evolving Paradigm
Anton J. Bilchik et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy
Rene Adam et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group
Bernard Nordlinger et al.
EUROPEAN JOURNAL OF CANCER (2007)
Guidelines for resection of colorectal cancer liver metastases
O. J. Garden et al.
GUT (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Neoadjuvant treatment of unresectable colorectal liver metastases:: correlation between tumour response and resection rates
G Folprecht et al.
ANNALS OF ONCOLOGY (2005)
The use of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer
GJ Poston
EJSO (2005)
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
A Grothey et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
